View this post on Instagram Three major Massachusetts hospitals are testing a Japanese drug that could be used to treat novel coronavirus patients, The Boston Globe reported, citing a doctor involved in the trials. The Food and Drug Administration approved a small, randomized trial of the antiviral drug called favipiravir at Massachusetts General Hospital and Brigham and Women's Hospital in Boston and UMass Memorial Medical Center in Worcester. "We have to prioritize, and this absolutely rose to the top," Dr. Keith T. Flaherty, who is leading a team of experts at MGH to review COVID-19 clinical trials, told the Globe. The Trump administration has reportedly been pushing the FDA to approve the drug known by its brand name Avigan and touted by Japanese Prime Minister Shinzo Abe as a possible treatment since late March, Politico reported, citing internal documents.A post shared by Fox Business (@foxbusiness) on Apr 9, 2020 at 2:00am PDT
Three major Massachusetts hospitals are testing a Japanese drug that could be used to treat novel coronavirus patients, The Boston Globe reported, citing a doctor involved in the trials. The Food and Drug Administration approved a small, randomized trial of the antiviral drug called favipiravir at Massachusetts General Hospital and Brigham and Women's Hospital in Boston and UMass Memorial Medical Center in Worcester. "We have to prioritize, and this absolutely rose to the top," Dr. Keith T. Flaherty, who is leading a team of experts at MGH to review COVID-19 clinical trials, told the Globe. The Trump administration has reportedly been pushing the FDA to approve the drug known by its brand name Avigan and touted by Japanese Prime Minister Shinzo Abe as a possible treatment since late March, Politico reported, citing internal documents.
A post shared by Fox Business (@foxbusiness) on Apr 9, 2020 at 2:00am PDT
